Latest Breaking News On - Okyo pharma limited nasdaq - Page 1 : comparemela.com

OKYO Pharma (OKYO) Withdraws Proposed Public Offering

OKYO Pharma (OKYO) Withdraws Proposed Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Okyo-pharma-limited-nasdaq
Freedom-capital-markets

OKYO Pharma (OKYO) Prices 2.67M Share Offering at $1.50/sh

OKYO Pharma (OKYO) Prices 2.67M Share Offering at $1.50/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Garys-jacob
Paul-spencer
Securities-exchange
Pharma-limited-nasdaq
Exchange-commission
Okyo-pharma-limited-nasdaq
Securities-act
Securities-exchange-act
Chief-executive

OKYO Pharma (OKYO) Announces Proposed Share Offering, Size not Disclosed

OKYO Pharma (OKYO) Announces Proposed Share Offering, Size not Disclosed
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Okyo-pharma-limited-nasdaq
Exchange-commission
Capital-markets
Bancroft-capital
Freedom-capital-markets

OKYO Pharma (OKYO) Withdraws Proposed Public Offering

OKYO Pharma (OKYO) to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain

OKYO Pharma (OKYO) to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Garys-jacob
Pedram-hamrah
Paul-spencer
Pharma-limited-nasdaq
Cornea-service
Translational-ocular-immunology-at-tufts-medical-center
Tufts-medical-center
Okyo-pharma-limited-nasdaq
Investigational-new-drug
Vice-chair
Academic-programs
Translational-ocular-immunology